Investment entities like
Oak Harvest Investment Services and
KBC Group NV are significantly
increasing their holdings in
Medtronic plc (MDT). Renowned investor
Jim Cramer applauds the recent strategies of the company. Analysts, however, have a mixed outlook – while some like
UBS and
Evercore ISI keep neutral ratings or lower price targets, others such as
Needham and
Stifel set higher price targets banking on
Momentum Through Diabetes and Cardiovascular Operations, or
Positive Outlook on HUGO Robotic System.
Mizuho and
Truist have a positive yet precautionary view ahead of the next quarter. Major plans such as
bkActiv-Stealth AXiS Integration, an
FDA approval for their
OmniaSecure and a partnership expansion with
Merrit Medical give the company potential for growth. Albeit, their stock has been under pressure with
bearish options activity, possibly due to the
MiniMed IPO announcement
Medtronic Plc MDT News Analytics from Tue, 19 Aug 2025 07:00:00 GMT to Sat, 18 Apr 2026 12:11:52 GMT -
Rating 2
- Innovation 7
- Information 8
- Rumor -5
